US20080177568A1 - Method and System for Pay-Per-Use Prescription Validation - Google Patents

Method and System for Pay-Per-Use Prescription Validation Download PDF

Info

Publication number
US20080177568A1
US20080177568A1 US11/626,660 US62666007A US2008177568A1 US 20080177568 A1 US20080177568 A1 US 20080177568A1 US 62666007 A US62666007 A US 62666007A US 2008177568 A1 US2008177568 A1 US 2008177568A1
Authority
US
United States
Prior art keywords
information
pharmacy
validation
validation system
contents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/626,660
Inventor
Petros Kotidis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axsun Technologies LLC
Original Assignee
Axsun Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axsun Technologies LLC filed Critical Axsun Technologies LLC
Priority to US11/626,660 priority Critical patent/US20080177568A1/en
Assigned to AXSUN TECHNOLOGIES, INC. reassignment AXSUN TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KOTIDIS, PETROS
Publication of US20080177568A1 publication Critical patent/US20080177568A1/en
Assigned to VOLCANO CORPORATION reassignment VOLCANO CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AXSUN TECHNOLOGIES, INC.
Priority to US14/588,127 priority patent/US10402543B2/en
Assigned to AXSUN TECHNOLOGIES, INC. reassignment AXSUN TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: VOLCANO CORPORATION
Assigned to AXSUN TECHNOLOGIES LLC reassignment AXSUN TECHNOLOGIES LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AXSUN TECHNOLOGIES, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/10Office automation; Time management
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/04Billing or invoicing
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Definitions

  • Improperly filled prescriptions represent a substantial risk of injury to customers at pharmacies.
  • Filling prescriptions is a generally commoditized business where the objective is to maximize the number of prescriptions filled by each pharmacist per hour. It is inevitable that some prescriptions are filled with the incorrect drugs or medication.
  • U.S. Pat. No. 6,771,369 concerns a system and method for pharmacy validation and inspection.
  • the disclosed system provides a combination of a bar code reader and a spectroscopy system.
  • a container of pills is provided with a label containing prescription information for a specific patient.
  • the label is read by the system's bar code reader.
  • the spectral response of the pills contained within the container is also resolved.
  • a data analysis system then compares the information from the bar code reader with the spectral response information to ensure that the chemical content of the pills within the container matches the prescription.
  • Such systems provide a way of confirming the accuracy of a filled prescription. Specifically, they insure that the contents of the container match the container's label. In this way, errors in prescriptions could be reduced.
  • the present invention is directed to a business model for facilitating the deployment of prescription validation systems into pharmacies.
  • pharmacies for little or no up-front cost to the pharmacy.
  • the pharmacy is charged on a per use basis, i.e., charged every time a prescription is validated in the system or based on entirely or in part on the number of validations performed.
  • the system vendor obtains payment on a subscription basis.
  • up-front costs at the pharmacy are avoided.
  • risks to a pharmacy concerning maintenance and slow productivity are avoided, or shifted onto the system owner, who is able to assess those risks.
  • Payment per validation business model is similar to other business models used in the pharmacy industry. For example, currently, a process of “adjudication” is used whereby a pharmacist confirms the level of insurance of a given customer. Specifically, when a customer seeks to fill a prescription, the pharmacist will usually contact an insurance information clearing house, which provides the pharmacist with information concerning the level of coverage for that specific customer. In this way, the pharmacy can handle prescriptions from customers having different insurance and different coverage levels, while being assured that the insurance company will provide the expected level of reimbursement.
  • FIG. 1 is a schematic diagram of a prescription validation system used in the present invention.
  • FIG. 2 is a flow diagram illustrating a method for prescription validation and charges to a pharmacy.
  • FIG. 1 shows a prescription validation system that is used in connection with the present invention, in one example.
  • the validation system 100 is used to analyze the contents of a container, such as a pill container 50 .
  • a container 50 typically representing a filled prescription, with a prescription specific label 52 on its outer surface, is placed within an analysis area 110 of the validation system 100 .
  • both a spectrometer 114 and vision system 116 are oriented to view the contents of the container 50 , usually near its mouth 54 .
  • the vision system 116 is used to check the shape, color, and symbols found on pills, for example, within the container 50 .
  • the spectrometer 114 is used to collect the spectroscopic response of those same drugs, such as pills, within the container 50 .
  • a label reader 112 reads the prescription information found on the label 52 .
  • the label reader has an optical character recognition (OCR) system to decode the human-readable information encoded on the label 52 .
  • OCR optical character recognition
  • the label reader alternatively, or in addition, comprises a machine code reading component such as a bar code reader that reads a machine-readable, e.g., bar code, found on the label 52 .
  • the prescription information from the label reader 112 , the spectroscopic information from the spectrometer 114 , and the pill shape, color, and symbol information from the vision system 116 are analyzed by the prescription validation system controller 120 .
  • the controller 120 confirms whether the prescription has been properly filled. Specifically, the prescription information found on the label 52 is compared to the pill shape, color, and/or symbols that were determined by the vision system 116 and the composition of those pills as determined by the spectrometer 114 .
  • the prescription validation system controller 120 connects to a pharmacy management system 130 .
  • This contains the pharmacy's database for the drugs and/or drugs held by the pharmacy and/or the existing customers serviced by the pharmacy.
  • the prescription validation system controller 120 confirms the prescription information on the label 52 is consistent with this back office system, for example, based on scheduled prescriptions to be filled at the pharmacy. That is, in one embodiment, the pharmacy management system comprises customer information and pending prescriptions to be filled. These prescription orders are then assigned to pharmacists at each validation system 100 .
  • the pharmacy management system 130 updates the queue of prescriptions to be filled and confirms the validated prescriptions were to be filled.
  • the prescription validation system controller 120 is also connected to a drug information center database 140 .
  • connection is a data connection across a public network, such as the internet.
  • the connection is supported by a dial-up connection or other direct point-to-point data communication.
  • This drug information center includes databases of spectroscopic pill information and pill shape, color and symbol information.
  • FIG. 2 shows the method of operation for the present invention.
  • a prescription is received and entered into the billing/back office pharmacy management system 130 of the pharmacy.
  • Most pharmacies have such a database system that stores previous prescriptions by a patient, the number of refills left on those prescriptions, insurance information for patients, billing information, and other account information.
  • the system also controls pharmacy workflow in some examples so that prescriptions to be filled are distributed among the working pharmacists.
  • the billing/back office pharmacy management system 130 contacts an insurance coverage clearing house. This step is often referred to as adjudication where the pharmacy determines whether the patient is covered, the insurance company, and the level of coverage to determine the level of reimbursement that the pharmacy will be receive from the customers' insurance.
  • step 214 the drug is dispensed. Often, this filling is performed manually by pharmacist who puts a prescribed number of pills, for example, into the container 50 .
  • step 216 pharmacist affixes the label 52 to the container 50 . Often this label 52 is printed directly by the billing/back office system 130 for the pharmacy.
  • the steps of filling the container and/or printing and affixing the prescription label 52 to the container 50 are performed by an automated system. Especially in large pharmacies, there are machines that take entered prescription information and then automatically dispense the drugs into the containers 50 , including the required labels 52 .
  • the container 50 is placed in the analysis area 110 (see FIG. 1 ).
  • step 220 the validation system 100 acquires a spectroscopic data of the drug. Specifically the spectrometer 114 determines the spectral response of the pills contained in the container 50 .
  • the validation system 100 also preferably acquires image information for the pills using the vision system 116 .
  • this image recognition information includes the shape, color and any symbols contained on the pills.
  • the validation system controller 120 searches for a match in an internal database 122 in step 224 . The system then determines whether or not there is a match for the pills based on the color, shape, symbols on the pills and/or the spectroscopic data on the pills in step 226 . If no match is found, then in step 228 , the validation system sends the spectroscopic, shape, color data, to the drug information center 140 .
  • step 230 the drug information center 140 receives this spectroscopic and/or image recognition information from the validation system in step 230 . It searches in the center's database for a match. The drug center 140 then sends match information to the validation system 100 in step 232 or signals an error condition with no match being found.
  • the center 140 signals for a recalibration of the validation system 100 , usually including a recalibration of the spectroscopy system 114 .
  • the validation system 100 reads the label 52 and/or receives intended prescription information from the billing/back office system 130 . Specifically, the validation system 100 or management system 130 validates that a request for this prescription exists, that the drugs in the container match both the label 52 on the container 50 and the intended prescription in the back office system 130 .
  • step 236 the validation system 100 notifies the pharmacist of a match or an invalid condition. That is, if there is a detected error in the data, the system signals that the particular prescription has not been properly filled.
  • the drug center 140 also sends an update with the spectroscopic, shape, and color symbol data for the internal database 122 of the validation system controller 120 .
  • the drug center 140 updates the internal database 122 , in one embodiment, of the validation system controller 120 based upon the requests that the validation sent in 228 . In this way, the validation system controller will signal a match if a similar drug is presented to the validation system in the future.
  • the validation system controller 120 then updates its internal database 122 with the new spectroscopic, shape, color and symbol data from the drug center 140 .
  • the validation system controller 120 notifies the drug information center 140 of the validation.
  • the drug information center updates the pharmacy's billing information with this validation.
  • the center 140 periodically sends a bill to the pharmacy. The charges are based on the number of validations that were performed over the billing period. In other examples the bill also includes rental or lease changes for the validation system 100 for the billing period.
  • the pharmacy system notifies the center with accuracy information concerning the accuracy with which prescriptions are being filled at the pharmacy and any errors originating from the validation system 100 in step 246 .
  • step 248 the drug center further updates its record information with this information from the local validation system at their pharmacy.
  • the drug information center 140 periodically sends general updates for the internal database of the validation system. These internal updates are used, in one embodiment, to increase the probability of a match when the validation system 100 interrogates its internal database. For example, as the composition of pills, specifically pill coatings change, and/or with changes in color and introduction of instruction of new and generic pills, this information is continually sent by the drug information center 140 to update the internal database 122 of each validation system 100 at each pharmacy. Then, finally, in step 252 , the pharmacy validation system updates its internal database with the new data for its validation system.

Abstract

A business model for facilitating the deployment of prescription validation systems into pharmacies is installed in pharmacies for little or no up-front cost to the pharmacy. Instead, the pharmacy is charged on a per use basis, that is, charged every time a prescription is validated in the system. In this way, the system vendor obtains payment on a subscription-like basis. Up-front costs at the pharmacy are avoided. Moreover, risks to a pharmacy concerning maintenance and slow productivity are avoided, or shifted onto the system owner, who is able to assess those risks.

Description

    BACKGROUND OF THE INVENTION
  • Improperly filled prescriptions represent a substantial risk of injury to customers at pharmacies. Filling prescriptions is a generally commoditized business where the objective is to maximize the number of prescriptions filled by each pharmacist per hour. It is inevitable that some prescriptions are filled with the incorrect drugs or medication.
  • To address this problem, systems for the validation of prescriptions have been proposed. For example, U.S. Pat. No. 6,771,369 concerns a system and method for pharmacy validation and inspection. The disclosed system provides a combination of a bar code reader and a spectroscopy system. In operation, a container of pills is provided with a label containing prescription information for a specific patient. The label is read by the system's bar code reader. Contemporaneously, the spectral response of the pills contained within the container is also resolved. A data analysis system then compares the information from the bar code reader with the spectral response information to ensure that the chemical content of the pills within the container matches the prescription. Such systems provide a way of confirming the accuracy of a filled prescription. Specifically, they insure that the contents of the container match the container's label. In this way, errors in prescriptions could be reduced.
  • SUMMARY OF THE INVENTION
  • The main impediment to the market penetration of prescription validation systems into the typical pharmacy is the cost of such systems. While there might be savings in terms of the pharmacy's liability insurance because of the decrease in the pharmacy's errors, the systems are comparatively expensive and represent an up-front cost to the typical pharmacy. Further, it is often unclear whether such systems will work accurately enough and at the speeds required in the pharmacy to justify investment. There are also risks to the pharmacy concerning costs of ownership including maintenance and equipment downtime.
  • The present invention is directed to a business model for facilitating the deployment of prescription validation systems into pharmacies. Specifically, these systems are installed in pharmacies for little or no up-front cost to the pharmacy. Instead, the pharmacy is charged on a per use basis, i.e., charged every time a prescription is validated in the system or based on entirely or in part on the number of validations performed. In this way, the system vendor obtains payment on a subscription basis. At the same time, up-front costs at the pharmacy are avoided. Moreover, risks to a pharmacy concerning maintenance and slow productivity are avoided, or shifted onto the system owner, who is able to assess those risks.
  • Payment per validation business model is similar to other business models used in the pharmacy industry. For example, currently, a process of “adjudication” is used whereby a pharmacist confirms the level of insurance of a given customer. Specifically, when a customer seeks to fill a prescription, the pharmacist will usually contact an insurance information clearing house, which provides the pharmacist with information concerning the level of coverage for that specific customer. In this way, the pharmacy can handle prescriptions from customers having different insurance and different coverage levels, while being assured that the insurance company will provide the expected level of reimbursement.
  • The above and other features of the invention including various novel details of construction and combinations of parts, and other advantages, will now be more particularly described with reference to the accompanying drawings and pointed out in the claims. It will be understood that the particular method and device embodying the invention are shown by way of illustration and not as a limitation of the invention. The principles and features of this invention may be employed in various and numerous embodiments without departing from the scope of the invention.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the accompanying drawings, reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale; emphasis has instead been placed upon illustrating the principles of the invention. Of the drawings:
  • FIG. 1 is a schematic diagram of a prescription validation system used in the present invention; and
  • FIG. 2 is a flow diagram illustrating a method for prescription validation and charges to a pharmacy.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1 shows a prescription validation system that is used in connection with the present invention, in one example.
  • The validation system 100 is used to analyze the contents of a container, such as a pill container 50. Specifically, in operation, a container 50, typically representing a filled prescription, with a prescription specific label 52 on its outer surface, is placed within an analysis area 110 of the validation system 100.
  • In one embodiment, both a spectrometer 114 and vision system 116 are oriented to view the contents of the container 50, usually near its mouth 54. The vision system 116 is used to check the shape, color, and symbols found on pills, for example, within the container 50. The spectrometer 114 is used to collect the spectroscopic response of those same drugs, such as pills, within the container 50.
  • Simultaneously or contemporaneously, in one embodiment, a label reader 112 reads the prescription information found on the label 52. In one example, the label reader has an optical character recognition (OCR) system to decode the human-readable information encoded on the label 52. In another example, the label reader alternatively, or in addition, comprises a machine code reading component such as a bar code reader that reads a machine-readable, e.g., bar code, found on the label 52.
  • The prescription information from the label reader 112, the spectroscopic information from the spectrometer 114, and the pill shape, color, and symbol information from the vision system 116 are analyzed by the prescription validation system controller 120. The controller 120 confirms whether the prescription has been properly filled. Specifically, the prescription information found on the label 52 is compared to the pill shape, color, and/or symbols that were determined by the vision system 116 and the composition of those pills as determined by the spectrometer 114.
  • According to the invention, the prescription validation system controller 120 connects to a pharmacy management system 130. This contains the pharmacy's database for the drugs and/or drugs held by the pharmacy and/or the existing customers serviced by the pharmacy. The prescription validation system controller 120 confirms the prescription information on the label 52 is consistent with this back office system, for example, based on scheduled prescriptions to be filled at the pharmacy. That is, in one embodiment, the pharmacy management system comprises customer information and pending prescriptions to be filled. These prescription orders are then assigned to pharmacists at each validation system 100. As prescriptions are validated, the pharmacy management system 130 updates the queue of prescriptions to be filled and confirms the validated prescriptions were to be filled.
  • The prescription validation system controller 120 is also connected to a drug information center database 140. In one example, connection is a data connection across a public network, such as the internet. In other examples, the connection is supported by a dial-up connection or other direct point-to-point data communication. This drug information center includes databases of spectroscopic pill information and pill shape, color and symbol information.
  • FIG. 2 shows the method of operation for the present invention.
  • As is common, in step 210, a prescription is received and entered into the billing/back office pharmacy management system 130 of the pharmacy. Most pharmacies have such a database system that stores previous prescriptions by a patient, the number of refills left on those prescriptions, insurance information for patients, billing information, and other account information. The system also controls pharmacy workflow in some examples so that prescriptions to be filled are distributed among the working pharmacists.
  • Then, the billing/back office pharmacy management system 130 contacts an insurance coverage clearing house. This step is often referred to as adjudication where the pharmacy determines whether the patient is covered, the insurance company, and the level of coverage to determine the level of reimbursement that the pharmacy will be receive from the customers' insurance.
  • Then in step 214, the drug is dispensed. Often, this filling is performed manually by pharmacist who puts a prescribed number of pills, for example, into the container 50. In step 216, pharmacist affixes the label 52 to the container 50. Often this label 52 is printed directly by the billing/back office system 130 for the pharmacy.
  • In other examples, the steps of filling the container and/or printing and affixing the prescription label 52 to the container 50 are performed by an automated system. Especially in large pharmacies, there are machines that take entered prescription information and then automatically dispense the drugs into the containers 50, including the required labels 52. In step 218, the container 50 is placed in the analysis area 110 (see FIG. 1).
  • In step 220, the validation system 100 acquires a spectroscopic data of the drug. Specifically the spectrometer 114 determines the spectral response of the pills contained in the container 50.
  • In step 222, the validation system 100 also preferably acquires image information for the pills using the vision system 116. Preferably this image recognition information includes the shape, color and any symbols contained on the pills.
  • Based on the spectroscopic and image information, the validation system controller 120 searches for a match in an internal database 122 in step 224. The system then determines whether or not there is a match for the pills based on the color, shape, symbols on the pills and/or the spectroscopic data on the pills in step 226. If no match is found, then in step 228, the validation system sends the spectroscopic, shape, color data, to the drug information center 140.
  • In step 230 the drug information center 140 receives this spectroscopic and/or image recognition information from the validation system in step 230. It searches in the center's database for a match. The drug center 140 then sends match information to the validation system 100 in step 232 or signals an error condition with no match being found.
  • In the event of a non-match at the center's database, the center 140 signals for a recalibration of the validation system 100, usually including a recalibration of the spectroscopy system 114.
  • Based upon the match information from the drug center 140 or determined internally by reference to the database 122 of the validation system controller 120, in step 224, the validation system 100 reads the label 52 and/or receives intended prescription information from the billing/back office system 130. Specifically, the validation system 100 or management system 130 validates that a request for this prescription exists, that the drugs in the container match both the label 52 on the container 50 and the intended prescription in the back office system 130.
  • Then in step 236, the validation system 100 notifies the pharmacist of a match or an invalid condition. That is, if there is a detected error in the data, the system signals that the particular prescription has not been properly filled.
  • In step 238, the drug center 140 also sends an update with the spectroscopic, shape, and color symbol data for the internal database 122 of the validation system controller 120. Specifically, the drug center 140 updates the internal database 122, in one embodiment, of the validation system controller 120 based upon the requests that the validation sent in 228. In this way, the validation system controller will signal a match if a similar drug is presented to the validation system in the future. In step 240, the validation system controller 120 then updates its internal database 122 with the new spectroscopic, shape, color and symbol data from the drug center 140.
  • According to the step 242, the validation system controller 120 notifies the drug information center 140 of the validation. In step 224, the drug information center updates the pharmacy's billing information with this validation. In one embodiment, the center 140 periodically sends a bill to the pharmacy. The charges are based on the number of validations that were performed over the billing period. In other examples the bill also includes rental or lease changes for the validation system 100 for the billing period.
  • Often, the validations will cost only a few cents. Also, in one embodiment, the pharmacy system notifies the center with accuracy information concerning the accuracy with which prescriptions are being filled at the pharmacy and any errors originating from the validation system 100 in step 246.
  • In step 248, the drug center further updates its record information with this information from the local validation system at their pharmacy.
  • In step 250, the drug information center 140 periodically sends general updates for the internal database of the validation system. These internal updates are used, in one embodiment, to increase the probability of a match when the validation system 100 interrogates its internal database. For example, as the composition of pills, specifically pill coatings change, and/or with changes in color and introduction of instruction of new and generic pills, this information is continually sent by the drug information center 140 to update the internal database 122 of each validation system 100 at each pharmacy. Then, finally, in step 252, the pharmacy validation system updates its internal database with the new data for its validation system.
  • While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.

Claims (13)

1. A method for prescription validation, comprising:
a pharmacy validation system for performing validations by determining whether labels for containers correspond to contents of the containers;
the validation system sending information that the validation was made to an information center; and
the information center billing the pharmacy based on a number of validations performed by the validation system.
2. A method as claimed in claim 1, wherein the pharmacy validation system comprises: a label reader for reading information encoded on the label.
3. A method as claimed in claim 2, wherein the pharmacy validation system further comprises at least one of a machine recognition system for determining a shape of, color of, and/or symbols on contents of the container and a spectroscopy system for determining a spectral response of the contents of the container, wherein the step of validating the prescription comprises comparing information from the machine recognition system and the spectroscopy system to information on the labels.
4. A method as claimed in claim 1, wherein the step of the validation system sending information that the validation was made comprises the validation system informing the information center when each validation is made.
5. A method as claimed in claim 1, wherein the step of the validation system sending information that the validation was made comprises the validation system periodically informing the information center information as to a number of validations made over a time period.
6. A method as claimed in claim 1, wherein the step of the information center billing the pharmacy comprises the information center periodically sending a bill based at least in part on a number of validations performed over a period by the validation system of the pharmacy.
7. A method as claimed in claim 1, wherein the step of the information center billing the pharmacy comprises the information center periodically sending a bill based in part on a number of validations performed over a period by the validation system of the pharmacy and in part based on rental or lease amount for the period.
8. A method as claimed in claim 1, further comprising an information center periodically updating an internal database of the validation system with spectroscopy information for drugs dispensed by the pharmacy.
9. A method as claimed in claim 1, further comprising the validation system confirming that information from the validations correspond to prescriptions to be filled by a pharmacy by reference to a pharmacy management system.
10. A method for prescription validation, comprising:
a pharmacy validation system for analyzing contents of prescription containers by acquiring information from the contents;
the validation system searching for a match for the contents of containers in an internal database and sending the information, including a spectroscopic response of the contents, to a drug information center if no match is found in the internal database;
drug information center notifying the pharmacy validation system of the contents.
11. (canceled)
12. A method as claimed in claim 10, wherein the information includes a shape and color the contents.
13. A method as claimed in claim 10, further comprising drug information center sending updates for the internal database in response to the information requests when no match was found.
US11/626,660 2007-01-24 2007-01-24 Method and System for Pay-Per-Use Prescription Validation Abandoned US20080177568A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US11/626,660 US20080177568A1 (en) 2007-01-24 2007-01-24 Method and System for Pay-Per-Use Prescription Validation
US14/588,127 US10402543B2 (en) 2007-01-24 2014-12-31 Method and system for pay-per-use prescription validation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/626,660 US20080177568A1 (en) 2007-01-24 2007-01-24 Method and System for Pay-Per-Use Prescription Validation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/588,127 Continuation US10402543B2 (en) 2007-01-24 2014-12-31 Method and system for pay-per-use prescription validation

Publications (1)

Publication Number Publication Date
US20080177568A1 true US20080177568A1 (en) 2008-07-24

Family

ID=39642135

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/626,660 Abandoned US20080177568A1 (en) 2007-01-24 2007-01-24 Method and System for Pay-Per-Use Prescription Validation
US14/588,127 Active 2029-09-11 US10402543B2 (en) 2007-01-24 2014-12-31 Method and system for pay-per-use prescription validation

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/588,127 Active 2029-09-11 US10402543B2 (en) 2007-01-24 2014-12-31 Method and system for pay-per-use prescription validation

Country Status (1)

Country Link
US (2) US20080177568A1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090127339A1 (en) * 2007-11-18 2009-05-21 Needham Bradford H Medication recording device
US20110303564A1 (en) * 2010-06-14 2011-12-15 Trutag Technologies, Inc. System for producing a packaged item with an identifier
WO2011159338A1 (en) * 2010-06-14 2011-12-22 Trutag Technologies, Inc. System for verifying an item in a package
WO2011159336A1 (en) * 2010-06-14 2011-12-22 Trutag Technologies, Inc. System for verifying an item in a package using a database
US20120203565A1 (en) * 2011-02-07 2012-08-09 Mckesson Specialty Arizona Inc. Method and apparatus for providing improved patient medication adherence
US9514131B1 (en) * 2010-05-30 2016-12-06 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10492991B2 (en) 2010-05-30 2019-12-03 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4796181A (en) * 1986-10-24 1989-01-03 Wiedemer John D Billing system for computer software
US5925127A (en) * 1997-04-09 1999-07-20 Microsoft Corporation Method and system for monitoring the use of rented software
US20020091699A1 (en) * 2000-11-02 2002-07-11 Norton Phillip G. Hosted asset information management system and method
US20020137497A1 (en) * 2001-03-21 2002-09-26 Qwest Communications International Inc. Calling name information caching
US20030055683A1 (en) * 2001-09-19 2003-03-20 Gibson Jerry Tyrone System and method for disseminating drug information
US6771369B2 (en) * 2002-03-12 2004-08-03 Analytical Spectral Devices, Inc. System and method for pharmacy validation and inspection
US7028723B1 (en) * 2003-11-03 2006-04-18 Alouani Ali Tahar Apparatus and method for automatic prescription verification
WO2006074284A2 (en) * 2005-01-06 2006-07-13 Double Trump International Inc. Software licensing method and system
US20080162473A1 (en) * 2006-12-29 2008-07-03 Joachim Fitzer Performing a Query In a Database

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417539B2 (en) * 2003-04-16 2013-04-09 Optopo Inc. Machine vision and spectroscopic pharmaceutical verification

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4796181A (en) * 1986-10-24 1989-01-03 Wiedemer John D Billing system for computer software
US5925127A (en) * 1997-04-09 1999-07-20 Microsoft Corporation Method and system for monitoring the use of rented software
US20020091699A1 (en) * 2000-11-02 2002-07-11 Norton Phillip G. Hosted asset information management system and method
US20020137497A1 (en) * 2001-03-21 2002-09-26 Qwest Communications International Inc. Calling name information caching
US20030055683A1 (en) * 2001-09-19 2003-03-20 Gibson Jerry Tyrone System and method for disseminating drug information
US6771369B2 (en) * 2002-03-12 2004-08-03 Analytical Spectral Devices, Inc. System and method for pharmacy validation and inspection
US7028723B1 (en) * 2003-11-03 2006-04-18 Alouani Ali Tahar Apparatus and method for automatic prescription verification
WO2006074284A2 (en) * 2005-01-06 2006-07-13 Double Trump International Inc. Software licensing method and system
US20080162473A1 (en) * 2006-12-29 2008-07-03 Joachim Fitzer Performing a Query In a Database

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Cogdill, Process analytical technology case study, part III: Calibration monitoring and transfer, 2005, Volume 6, Number 2, Page E284-E297 *
Jenny, Causes of Unsatisfactory Performance in Proficiency Testing, 2000, Clinical Chemistry 46:1, Page 89-99 *

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8740077B2 (en) 2007-11-18 2014-06-03 Intel-Ge Care Innovations Llc Medication recording device
US8448846B2 (en) * 2007-11-18 2013-05-28 Intel-Ge Care Innovations Llc Medication recording device
US9144399B2 (en) 2007-11-18 2015-09-29 Intel-Ge Care Innovations Llc Medication recording device
US20090127339A1 (en) * 2007-11-18 2009-05-21 Needham Bradford H Medication recording device
US10813836B2 (en) 2010-05-30 2020-10-27 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10492991B2 (en) 2010-05-30 2019-12-03 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US10327987B1 (en) 2010-05-30 2019-06-25 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US9514131B1 (en) * 2010-05-30 2016-12-06 Crisi Medical Systems, Inc. Medication container encoding, verification, and identification
US8881972B2 (en) 2010-06-14 2014-11-11 Trutag Technologies, Inc. System for verifying an item in a package using a database
CN106408309A (en) * 2010-06-14 2017-02-15 特鲁塔格科技公司 System for verifying an item in a package using a database
US8596546B2 (en) 2010-06-14 2013-12-03 Trutag Technologies, Inc. System for verifying an item in a package
CN103189855A (en) * 2010-06-14 2013-07-03 特鲁塔格科技公司 System for verifying an item in a package using a database
CN103154929A (en) * 2010-06-14 2013-06-12 特鲁塔格科技公司 System for producing a packaged item with an identifier
US9033213B2 (en) * 2010-06-14 2015-05-19 Trutag Technologies, Inc. System for producing a packaged item with an identifier
KR20130057451A (en) * 2010-06-14 2013-05-31 트루테그 테크놀로지스, 인코포레이티드 System for producing a packaged item with an identifier
US11166874B2 (en) * 2010-06-14 2021-11-09 Trutag Technologies, Inc. System for producing a packaged item with an identifier
CN106296226A (en) * 2010-06-14 2017-01-04 特鲁塔格科技公司 For producing the system of the packaging article with identifier
JP2013530469A (en) * 2010-06-14 2013-07-25 トルタグ・テクノロジーズ・インコーポレーテッド A system for verifying products in a package
US10195109B2 (en) * 2010-06-14 2019-02-05 Trutag Technologies, Inc. System for producing a packaged item with an identifier
US10269022B2 (en) 2010-06-14 2019-04-23 Trutag Technologies, Inc. System for verifying an item in a package using a database
US20190167521A1 (en) * 2010-06-14 2019-06-06 Trutag Technologies, Inc. System for producing a packaged item with an identifier
WO2011159336A1 (en) * 2010-06-14 2011-12-22 Trutag Technologies, Inc. System for verifying an item in a package using a database
WO2011159338A1 (en) * 2010-06-14 2011-12-22 Trutag Technologies, Inc. System for verifying an item in a package
US20110303564A1 (en) * 2010-06-14 2011-12-15 Trutag Technologies, Inc. System for producing a packaged item with an identifier
US20120203565A1 (en) * 2011-02-07 2012-08-09 Mckesson Specialty Arizona Inc. Method and apparatus for providing improved patient medication adherence

Also Published As

Publication number Publication date
US20150112714A1 (en) 2015-04-23
US10402543B2 (en) 2019-09-03

Similar Documents

Publication Publication Date Title
US10402543B2 (en) Method and system for pay-per-use prescription validation
US8295977B2 (en) Medicine dispenser
US8700209B2 (en) Method and system for electronic assistance in dispensing pharmaceuticals
US7111780B2 (en) Automated drug substitution, verification, and reporting system
US8849449B2 (en) Method, system and apparatus for dispensing drugs
US8939365B1 (en) Systems controlled by data bearing records for maintaining inventory data
AU702845B2 (en) An automated medical prescription fulfillment system including bar code scanner
US6871783B2 (en) Method of dispensing medical prescriptions
US8374965B2 (en) System and method for verifying the contents of a filled, capped pharmaceutical prescription
US20040133705A1 (en) Controller for dispensing products
US20090012820A1 (en) Medication dose administration and inventory management
US20080128482A1 (en) Drug dispense, identification, labeling and the system of inspection
CN1543628A (en) Pos system having time-of-consumption management function of sales commodities
WO2013161694A1 (en) Drug dispensing system
KR20200031549A (en) A system for providing drug information using a block chain and method thereof
JP2012130779A (en) Medicine dispensing device
CN1759359A (en) Process delay monitoring system
US7860604B2 (en) Method for controlling access to and segregating dispensed items
JP5472917B2 (en) Transaction processing terminal device
CN1701328A (en) Hand-held inventory tracking and automated order transmission system
US20090319293A1 (en) Virtual inventory system and methods for covered entities
JP2002143273A (en) Medicine supplementing system for medical institution

Legal Events

Date Code Title Description
AS Assignment

Owner name: AXSUN TECHNOLOGIES, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KOTIDIS, PETROS;REEL/FRAME:019066/0222

Effective date: 20070322

AS Assignment

Owner name: VOLCANO CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AXSUN TECHNOLOGIES, INC.;REEL/FRAME:034059/0090

Effective date: 20140826

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: AXSUN TECHNOLOGIES, INC., MASSACHUSETTS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VOLCANO CORPORATION;REEL/FRAME:036952/0260

Effective date: 20151005

Owner name: AXSUN TECHNOLOGIES LLC, MASSACHUSETTS

Free format text: CHANGE OF NAME;ASSIGNOR:AXSUN TECHNOLOGIES, INC.;REEL/FRAME:037042/0660

Effective date: 20151016